Streetbeat News

Regulatory

BTCUSD

DOGEUSD

Dogecoin (DOGE) experienced a 14% increase to $0.22, influenced by Bitcoin's (BTC) surge past $70,000 and optimism from Elon Musk's payment company's expansion. Dogecoin's market cap exceeded $30 billion, marking a significant milestone. Bitcoin's rally is attributed to demand following the approval of spot bitcoin ETFs, despite recent outflows. The crypto market rebounded after dovish remarks from the Federal Reserve. Additionally, Bitcoin spot ETFs and BlackRock's iShares Bitcoin Trust saw significant inflows, indicating growing confidence in Bitcoin.

Portfolio Pulse from Henry Khederian

March 29, 2024 | 1:47 am

APLT

Applied Therapeutics' stock is trading lower following the announcement that the FDA has extended the review period for the NDA of govorestat, aimed at treating Classic Galactosemia, by three months.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:50 pm

VSTO

Vista Outdoor and Czechoslovak Group a.s. (CSG) have re-filed their notice for the proposed sale of The Kinetic Group to CSG with the Committee on Foreign Investment in the United States (CFIUS) to allow more time for a thorough review. This step is part of the standard review process by CFIUS, which permits parties to re-file to ensure a comprehensive evaluation.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:39 pm

APLT

The FDA has extended the review period for Applied Therapeutics' NDA for Govorestat (AT-007), aimed at treating Classic Galactosemia, by three months, setting a new PDUFA target action date to November 28, 2024. This extension is due to the FDA requiring more time to review supplemental analyses of previously submitted data by Applied Therapeutics, which is considered a Major Amendment to the NDA. Despite the delay, Applied Therapeutics remains confident in Govorestat's approval prospects.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:32 pm

BMY

Bristol Myers Squibb (BMY) announced positive results from the Phase 3 KRYSTAL-12 study of KRAZATI (adagrasib) for treating KRASG12C-mutated non-small cell lung cancer, meeting primary and key secondary endpoints. The study showed significant benefits in progression-free survival and overall response rate, with safety data consistent with known profiles. KRAZATI has received FDA accelerated approval and is under review for additional indications.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 8:12 pm

MESO

Mesoblast shares are trading higher following the FDA's indication that the clinical data from its Phase 3 study MSB-GVHD001 seems adequate to support the submission of a Biologics License Application for remestemcel-L.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 7:42 pm

CEIX

COAL

IYM

The collapse of the Francis Scott Key Bridge, leading to the shutdown of the Port of Baltimore, has caused a rise in coal prices and impacted the stock prices of the Range Global Coal ETF (COAL) and Consol Energy Inc (CEIX). The port, a major coal export hub, accounts for 28% of U.S. coal exports, significantly affecting coal export volumes. The incident also impacts metal imports and has led to a rise in aluminum futures, affecting the iShares U.S. Basic Materials ETF (IYM).

Portfolio Pulse from Neil Dennis

March 28, 2024 | 7:24 pm

MA

V

Visa Inc (NYSE:V) and Mastercard Inc (NYSE:MA) have reached a $30 billion settlement with U.S. merchants, ending two decades of antitrust litigation over swipe fees and merchant restrictions. The settlement includes capping credit interchange rates for five years, offering savings to merchants, and enhancing consumer payment options. Meanwhile, credit card APRs are on the rise, with the average new card offer at 24.66%, despite the Federal Reserve's current stance on rates.

Portfolio Pulse from Surbhi Jain

March 28, 2024 | 7:20 pm

TCNNF

The Florida Supreme Court did not issue a ruling on proposed amendments for cannabis legalization and abortion rights, causing uncertainty ahead of the April 1 deadline. Trulieve Cannabis (OTCQX:TCNNF), criticized by Florida's AG for supporting the cannabis initiative, is involved in the controversy. The outcome could impact the presidential election dynamics.

Portfolio Pulse from Maureen Meehan

March 28, 2024 | 7:04 pm

DIS

Blackwells Capital has initiated a lawsuit against Walt Disney in a Delaware court, aiming to access books and records to investigate potential disclosure violations related to its interactions with the hedge fund ValueAct, according to a court filing.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 6:38 pm